menu
    • menu

    Company profile for Vectura Ltd

    Skyepharma-PSE
    News
    Vectura Fertin Pharma Announces Sale Agreement To Molex,Philip Morris Subsidiary

    17 Sep 2024

    // BUSINESSWIRE

    Aurora Cannabis And Vectura Fertin Pharma Announce Collaboration

    01 Aug 2024

    // PR NEWSWIRE

    Vectura’s Inhalation Center of Excellence Granted Planning Permission

    27 Sep 2022

    // CONTRACT PHARMA

    DATA COMPILATION
    #PharmaFlow

    Skyepharma RM

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Vectura’s portfolio has emerged from the Company’s product development, formulation and drug delivery expertise and is currently centred around developing inhaled products to address unmet needs in airways diseases. We continue to focus on balancing the unmet needs of all stakeholders (patients, physicians, payors) with commercial attractiveness and exploiting valuable niches in our therapeutic space.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vectura Ltdunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    1 Prospect West, Chippenham, Wiltshire
    Telephone
    Telephone
    +33 474952020
    Client Email
    Email
    info@skyepharma.com
    Client Website
    Website
    https://www.vectura.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/vectura
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/vecturagroup
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Vectura Fertin Pharma Announces Sale Agreement To Molex,Philip Morris Subsidiary
    Vectura Fertin Pharma Announces Sale Agreement To Molex,Philip Morris Subsidiary

    17 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917390554/en

    BUSINESSWIRE
    17 Sep 2024
    Share Share
    Aurora Cannabis And Vectura Fertin Pharma Announce Collaboration
    Aurora Cannabis And Vectura Fertin Pharma Announce Collaboration

    01 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aurora-cannabis-and-vectura-fertin-pharma-inc-announce-commercial-collaboration-302212087.html

    PR NEWSWIRE
    01 Aug 2024
    Share Share
    Vectura’s Inhalation Center of Excellence Granted Planning Permission
    Vectura’s Inhalation Center of Excellence Granted Planning Permission

    27 Sep 2022

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-27/vecturas-inhalation-center-of-excellence-granted-planning-permission/?widget=listSection

    CONTRACT PHARMA
    27 Sep 2022
    Share Share
    Executive Changes at Vectura
    Executive Changes at Vectura

    31 Mar 2022

    // PRESS RELEASE

    https://www.vectura.com/about/news/executive-changes-at-vectura/

    PRESS RELEASE
    31 Mar 2022
    Share Share
    Vectura wins Mediscience’s Best Communication Award
    Vectura wins Mediscience’s Best Communication Award

    17 Nov 2021

    // PRESS RELEASE

    https://www.vectura.com/about/news/vectura-wins-medisciences-best-communication-award/

    PRESS RELEASE
    17 Nov 2021
    Share Share
    How Philip Morris deal may affect Vectura’s sales of lung therapies
    How Philip Morris deal may affect Vectura’s sales of lung therapies

    09 Oct 2021

    // CORINNE GRETLER BUSINESSLIVE

    https://www.businesslive.co.za/bd/companies/2021-10-11-how-philip-morris-deal-may-affect-vecturas-sales-of-lung-therapies/

    CORINNE GRETLER BUSINESSLIVE
    09 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search